We seem to have good reason for confidence over the outcome of the current trials. What seems to be lacking is a model of what success would mean from a financial perspective. Parameters embedded in such a model could be heavily qualified but still giving a feel for possible turnover and value.
If I were a potential buyer of FTT shares at this stage of product life cycle - I would be looking for this data.
We seem to have good reason for confidence over the outcome of...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable